| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,223 | 12,988 | 9,711 | 28,353 | | Cost of Revenue | 5,691 | 10,231 | 5,099 | 10,196 | | | Gross Profit | 4,532 | 2,757 | 4,612 | 18,157 | | | Operating Expenses | | Research Development | 23,474 | 24,150 | 23,890 | 45,279 | | Selling General and Administrative | 9,917 | 9,087 | 11,020 | 14,546 | | Non Recurring |
-
|
-
|
-
| (68,114) | | Others |
-
|
-
|
-
| (710) | | | | Total Operating Expenses |
-
|
-
|
-
| (8,999) | | | | Operating Income or Loss | (28,859) | (30,480) | (30,298) | 27,156 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 680 | 1,153 | 1,695 | 51,641 | | Earnings Before Interest And Taxes | (28,179) | (29,327) | (28,603) | 78,797 | | Interest Expense | 2,928 | 2,948 | 3,337 | 3,357 | | Income Before Tax | (31,107) | (32,275) | (31,940) | 75,440 | | Income Tax Expense | (140) | (206) | (133) | (1,342) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (30,967) | (32,069) | (31,807) | 76,782 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (30,967) | (32,069) | (31,807) | 76,782 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($30,967) | ($32,069) | ($31,807) | $76,782 |
|
1.48% Nasdaq 
Income Statement
